Psilocybin, a psychedelic substance, is currently being explored as a potential treatment for various mental illnesses. Researchers are conducting clinical trials...
The Therapeutic Goods Administration (TGA) has rescheduled both MDMA and Psilocybin from Schedule 9 ‘prohibited substances’ to Schedule 8 ‘controlled...
